Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors
Shares of Zimmer Biomet Holdings Inc. ZBH shed 1.71% to $100.93 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.95% to 6,025.99 and Dow Jones Industrial Average DJIA falling 0.99% to 44,303.40.
Zimmer Biomet Holdings (ZBH) Receives a Buy from BTIG
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price
Why Is Zimmer Biomet Stock Trading Lower On Thursday?
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30. The orthopedic giant reported sales of $2.02 billion,
Which Is a Better Investment, IDEXX Laboratories, Inc. or Zimmer Biomet Holdings, Inc. Stock?
Learn more about whether IDEXX Laboratories, Inc. or Zimmer Biomet Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors
Shares of Zimmer Biomet Holdings Inc. ZBH slipped 5.14% to $102.69 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 6,083.57 and the Dow Jones Industrial Average DJIA falling 0.28% to 44,747.63.
Truist Financial Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).
Zimmer Biomet price target lowered to $113 from $118 at Truist
Truist analyst Richard Newitter lowered the firm’s price target on Zimmer Biomet (ZBH) to $113 from $118 and keeps a Hold rating on the shares.
Zimmer Biomet forecasts 2025 profit below estimates
Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...
Zimmer Biomet: Adding To The Growth Profile
Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...
MassDevice4d
Zimmer Biomet beats The Street in Q4
Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...
Zimmer Biomet to buy Paragon 28 for $1.1 billion
Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its ...
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details
Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...
MassDevice12d
Zimmer Biomet to buy Paragon 28 for $1.2B
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
Zimmer Biomet slips as outlook misses consensus
Despite reporting better-than-expected Q4 2024 results, shares of Zimmer Biomet (NYSE:ZBH) fell in the morning hours Thursday after the orthopedic device maker set its 2025 outlook below consensus.